Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Minority Interest (2020 - 2025)

Apyx Medical (APYX) has disclosed Minority Interest for 6 consecutive years, with $291000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Minority Interest rose 132.8% year-over-year to $291000.0, compared with a TTM value of $291000.0 through Dec 2025, up 132.8%, and an annual FY2025 reading of $291000.0, up 132.8% over the prior year.
  • Minority Interest was $291000.0 for Q4 2025 at Apyx Medical, up from $232000.0 in the prior quarter.
  • Across five years, Minority Interest topped out at $338000.0 in Q2 2021 and bottomed at $125000.0 in Q4 2024.
  • Average Minority Interest over 5 years is $221950.0, with a median of $220000.0 recorded in 2022.
  • The sharpest move saw Minority Interest tumbled 47.21% in 2023, then surged 132.8% in 2025.
  • Year by year, Minority Interest stood at $317000.0 in 2021, then tumbled by 30.91% to $219000.0 in 2022, then increased by 0.91% to $221000.0 in 2023, then plummeted by 43.44% to $125000.0 in 2024, then skyrocketed by 132.8% to $291000.0 in 2025.
  • Business Quant data shows Minority Interest for APYX at $291000.0 in Q4 2025, $232000.0 in Q3 2025, and $203000.0 in Q2 2025.